Radioimmunotherapy with (131)I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with (90)Y-Ibritumomab Tiuxetan

We report a case that demonstrates the efficacy of radioimmunotherapy (RIT) with radioiodinated rituximab ((131)I-rituximab) for relapsed diffuse large B-cell lymphoma (DLBCL). A 79-year-old male patient with DLBCL initially achieved a complete response (CR) after six cycles of R-CHOP (rituximab, cy...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kang, Geon Wook, Kang, Hye Jin, Shin, Dong-Yeop, Gu, Ha Ra, Choi, Hong Seok, Lim, Sang Moo
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2013
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4035173/
https://ncbi.nlm.nih.gov/pubmed/24900126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-013-0229-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires